Posts: Type 2 Diabetes
Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial
A very low calorie diet is changing the way we look at treating Type 2 Diabetes (T2D)1. A recent study, funded by Diabetes UK aimed to find an effective and accessible way to put T2D into remission2. Led by […]
Causality is a difficult concept in chronic disease. Rarely is it as simply explained as Koch’s Postulates was able to do with acute disease.
Attempts to assign a ‘linear’ relationship (i.e. presence of risk = development of disease) to chronic diseases often fall short of a comprehensive causal explanation vis. ‘diet’ as a singular cause of […]
Liraglutide 3·0 mg was shown to reduce bodyweight and improve glucose metabolism after the 56-week period of this trial, one of four trials in the SCALE programme. Read more
Slowing Down the Progression of Type 2 Diabetes: We Need Fair, Innovative, and Disruptive Action on Environmental and Policy Levels!
Over the past decades, we have observed an increase of prevalence of diabetes in many countries along with significant differences in prevalence trends between countries worldwide (1). In Europe and other Western countries, the prevalence rate reaches a plateau or has slowed down on the level of ∼8–10%. In Asia, a continuous rise in […]
Every day an estimated 280 Australians develop type 2 diabetes.1 By 2023, type 2 diabetes is predicted to become the number one specific cause of burden of disease in Australia.2 Policies and programs to support the prevention of type 2 diabetes need to be scaled up urgently if Australia hopes to limit or reduce the […]